Tip 2 Diyabet Tanılı Bireylerde Yeme ve Ağırlık Modelleri Anketi-5 (YAMA-5)'in Türkçe Geçerlik ve Güvenirlik Çalışması ve Anketin Diyabet Distress Ölçeği ile İlişkisinin İncelenmesi

Abstract

Type 2 Diabetes Mellitus (T2DM), often accompanied by insulin resistance, is a chronic and metabolic disease that causes disorders in carbohydrate, protein and fat metabolism. Especially in individuals with T2DM who have a high body mass index (BMI) and insulin resistance, there is a risk of developing various eating disorders, especially Binge Eating Disorder (BED). The aim of this study was to evaluate the Turkish validity and reliability of The Questionnaire of Eating and Weight Patterns-5 (QEWP-5) as a Binge Eating Disorder (BED) screening tool in individuals with Type 2 diabetes; and to examine the relationship between the questionnaire and some general characteristics of individuals, such as age, gender, BMI and duration of diabetes, and Diabetes Distress Scale (DDS) scores. In order to do this, 200 adults with Type 2 diabetes aged 19-64 participated in the study. The study questionnaire consists of four parts: "General Information", "Eating and Weight Patterns Questionnaire-5 (QEWP-5)", "Eating Disorder Examination Questionnaire (EDE-Q)" and "Diabetes Distress Scale (DDS)" and the questionnaire was administered to the participants via online interview. While the convergent validity of the validated QEWP-5 to Turkish showed a very strong correlation according to the Spearman coefficient (ρ=0,915 and p<0,001); the concurrent validity was found to show a good level of correlation according to the kappa coefficient (κ=0,632 for objective binge eating attack; κ=0,672 for subjective bulimic attack; κ=0,629 for objective bulimic attack). According to the test-retest results, the measurement reliability of QEWP-5 (κ=0,66) was found to be close to the accepted lower limit (κ=0,70). While probable BED was detected according to QEWP-5 in %4 of the individuals participating in the study, no individual was found to have Bulimia Nervosa. No statistically significant relationship was observed between the detection of possible BED in individuals according to QEWP-5 and the individuals' age, gender, educational status, average duration of diabetes, and treatment methods applied for diabetes (p>0,05). On the other hand, both body weight and BMI averages of individuals with possible BED were found to be significantly higher than those without (91,6±13,79/80,7±14,05 kg and 34,7±6,80/30,0±5,38 kg/m2, respectively; p<0,05). Individuals with possible BED according to QEWP-5; the mean of EDE-Q total and subscale scores and the median values of DDS total and subscale scores were found to be significantly higher than those not detected (p<0,05). The results obtained support that QEWP-5 can be used to screen for BED in individuals with Type 2 diabetes.